Chlormethiazole hydrochloride
SIGMA/C1240 - ≥98% (HPLC), powder
Synonym: 4-methyl-5-(β-chloroethyl)thiazole hydrochloride; 5-
CAS Number: 6001-74-7
Empirical Formula (Hill Notation): C6H8ClNS · HCl
Molecular Weight: 198.11
MDL Number: MFCD00673948
Linear Formula: C6H8ClNS · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | off-white |
| description | Store desiccated |
| form | powder |
| InChI | 1S/C6H8ClNS.ClH/c1-5-6(2- |
| InChI key | OFXYKSLKNMTBHK-UHFFFAOYSA |
| originator | AstraZeneca |
| Quality Level | 100 ![]() |
| SMILES string | Cl.Cc1ncsc1CCCl |
| solubility | H2O: soluble >10 mg/mL |
| Biochem/physiol Actions: | Chlormethiazole serves as an anticonvulsant. It is useful in treating alcohol addiction and eclampsia. Chlormethiazole is also useful in treating convulsive status epilepticus. Long term administration of chlormethiazole leads to addiction to the drug. |
| Biochem/physiol Actions: | GABAA agonist; glycine receptor modulator. |
| Features and Benefits: | This compound is a featured product for ADME Tox and Neuroscience research. Discover more featured ADME Tox and Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound was developed by AstraZeneca . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | ![]() GHS05,GHS07 |
| Signal word | Danger |
| Hazard statements | H302 - H317 - H318 |
| Precautionary statements | P280 - P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 + P310 |
| Hazard Codes | Xn |
| Risk Statements | 22-41-43 |
| Safety Statements | 26-36/37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352200 |



